These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4835126)

  • 1. A short calcium infusion in the diagnosis of medullary thyroid carcinoma.
    Parthemore JG; Bronzert D; Roberts G; Deftos LJ
    J Clin Endocrinol Metab; 1974 Jul; 39(1):108-11. PubMed ID: 4835126
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
    Linehan WM; Farrell RE; Cooper CW; Wells SA
    Surg Forum; 1977; 28():110-2. PubMed ID: 617389
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.
    Hennessy JF; Wells SA; Ontjes DA; Cooper CW
    J Clin Endocrinol Metab; 1974 Sep; 39(3):487-95. PubMed ID: 4471967
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation tests for diagnosis of medullary thyroid carcinoma.
    Sizemore GW; Go VL
    Mayo Clin Proc; 1975 Feb; 50(2):53-6. PubMed ID: 1117754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma.
    Jackson CE; Tashjian AH; Block MA
    J Lab Clin Med; 1971 Nov; 78(5):817-8. PubMed ID: 5128860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium controlling hormones and endocrinological tests].
    Fujita T
    Rinsho Byori; 1984 Jan; Spec No 58():78-86. PubMed ID: 6381811
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimmunoassay for calcitonin in medullary thyroid carcinoma.
    Deftos LJ
    JAMA; 1974 Jan; 227(4):403-6. PubMed ID: 4859674
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis.
    Graze K; Spiler IJ; Tashjian AH; Melvin KE; Cervi-Skinner S; Gagel RF; Miller HH; Wolfe HJ; DeLellis RA; Leape L; Feldman ZT; Reichlin S
    N Engl J Med; 1978 Nov; 299(18):980-5. PubMed ID: 692625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tests of stimulation of calcitonin secretion. Value in medullary cancer of the thyroid].
    Milhaud G; Ribeiro FM; Calmettes C; Taboulet J; Coutris G; Moukhtar MS
    Nouv Presse Med; 1975 Jun; 4(24):1793-5. PubMed ID: 1099542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
    Rude RK; Singer FR
    J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic applications of calcitonin immunoassay.
    Deftos LJ; Bronzert D; Parthemore JG
    Ann Clin Lab Sci; 1974; 4(6):484-6. PubMed ID: 4429342
    [No Abstract]   [Full Text] [Related]  

  • 15. Early diagnosis and treatment of medullary thyroid carcinoma.
    Wells SA; Dilley WG; Farndon JA; Leight GS; Baylin SB
    Arch Intern Med; 1985 Jul; 145(7):1248-52. PubMed ID: 4015274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proposal for the protocol of a national multidisciplinary study of medullary thyroid cancer].
    Trotoux J
    Ann Otolaryngol Chir Cervicofac; 1984; 101(4):331-4. PubMed ID: 6380375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome].
    Milhaud G; Coutris G; Tubiana M
    Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
    Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
    Rays; 2000; 25(2):257-66. PubMed ID: 11370543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
    Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary carcinoma of the thyroid.
    Corwin TR
    Surg Gynecol Obstet; 1974 Mar; 138(3):453-8. PubMed ID: 4590286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.